ANAVEX LIFE SCIENCES CORP.
Financial highlights
| Metric | FY September 30, 2025 | FY September 30, 2024 | FY September 30, 2023 | FY September 30, 2022 | FY September 30, 2021 |
|---|---|---|---|---|---|
| Operating income | -$51.4M | -$52.9M | -$55.8M | -$51.0M | -$42.0M |
| Operating expenses | $51.4M | $52.9M | $55.8M | $51.0M | $42.0M |
| Cash from operations | -$39.0M | -$30.8M | -$27.8M | -$24.2M | -$30.4M |
| Share repurchases | — | $11.3M | $27.9M | — | $24.1M |
| Total assets | $103.8M | $135.6M | $154.4M | $152.7M | $161.6M |
| Total liabilities | $8.9M | $15.3M | $12.5M | $10.2M | $10.8M |
Shares outstanding 92.7M · Free float 81.2%
Annual filing data through FY ended September 30, 2025; float as of July 12, 2026.